{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:33:02Z","timestamp":1793975582023,"version":"4.8.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143694"],"award-info":[{"award-number":["R01AI143694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX001350"],"award-info":[{"award-number":["I01 BX001350"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    New therapeutics are necessary for preventing\n                    <jats:italic>Plasmodium vivax<\/jats:italic>\n                    malaria due to easy transmissibility and dormancy in the liver that increases the clinical burden due to recurrent relapse. In this manuscript we characterize 12\u2009Pv Apical Membrane Antigen 1 (PvAMA1) specific human monoclonal antibodies from Peripheral Blood Mononuclear Cells of a Pv-exposed individual. PvAMA1 is essential for sporozoite and merozoite invasion, making it a unique therapeutic target. We show that humAb 826827 blocks the invasion of human reticulocytes using Pv clinical isolates and inhibits sporozoite invasion of human hepatocytes in vitro (IC\n                    <jats:sub>50<\/jats:sub>\n                    of 0.3 \u2013 3.7\u2009\u00b5g\/mL). Inoculation of human liver transgenic (FRG-humHep) female mice with humAb 826827 significantly reduces liver infection in vivo. The crystal structure of rPvAMA1 bound to 826827 shows that 826827 partially occupies the highly conserved hydrophobic groove in PvAMA1 that binds its known receptor, RON2. We have isolated a potent humAb that is isolate-transcendent, blocks both pre-erythrocytic and blood stage infection, and could be a potential therapy for Pv.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-53848-4","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:56:33Z","timestamp":1733288193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages"],"prefix":"10.1038","volume":"15","author":[{"given":"Anna C.","family":"Winnicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-4389","authenticated-orcid":false,"given":"Melanie H.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-762X","authenticated-orcid":false,"given":"Lee M.","family":"Yeoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore L.","family":"Carias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1789-0439","authenticated-orcid":false,"given":"Wanlapa","family":"Roobsoong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara L.","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa N.","family":"Malachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5073-0809","authenticated-orcid":false,"given":"Karli R.","family":"Redinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel Brice","family":"Feufack-Donfack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Baldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai C.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia S.","family":"McLaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelenna","family":"Skomorovska-Prokvolit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Orban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-4365","authenticated-orcid":false,"given":"D. Herbert","family":"Opi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payton","family":"Kirtley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8429-4840","authenticated-orcid":false,"given":"Kiersey","family":"Nielson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Aleshnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigliola","family":"Zanghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Rezakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-756X","authenticated-orcid":false,"given":"Ashley M.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5577-7787","authenticated-orcid":false,"given":"Brandon K.","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jetsumon","family":"Sattabongkot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-8699","authenticated-orcid":false,"given":"Wai-Hong","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3135-1175","authenticated-orcid":false,"given":"Jean","family":"Popovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-4105","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-7860","authenticated-orcid":false,"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"53848_CR1","doi-asserted-by":"crossref","unstructured":"Poespoprodjo, J. R. et al. Malaria. Lancet, 2023.","DOI":"10.1016\/S0140-6736(23)01249-7"},{"key":"53848_CR2","unstructured":"Menkin-Smith, L. & Winders, W. T. Plasmodium vivax Malaria, in StatPearls. 2023: Treasure Island (FL)."},{"key":"53848_CR3","doi-asserted-by":"publisher","first-page":"e1003799","DOI":"10.1371\/journal.pmed.1003799","volume":"18","author":"KE Battle","year":"2021","unstructured":"Battle, K. E. & Baird, J. K. The global burden of Plasmodium vivax malaria is obscure and insidious. PLoS Med 18, e1003799 (2021).","journal-title":"PLoS Med"},{"key":"53848_CR4","doi-asserted-by":"publisher","first-page":"e1003632","DOI":"10.1371\/journal.pmed.1003632","volume":"18","author":"S Kho","year":"2021","unstructured":"Kho, S. et al. Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study. PLoS Med 18, e1003632 (2021).","journal-title":"PLoS Med"},{"key":"53848_CR5","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMc2023884","volume":"384","author":"S Kho","year":"2021","unstructured":"Kho, S. et al. Hidden biomass of intact malaria parasites in the human spleen. N. Engl. J. Med 384, 2067\u20132069 (2021).","journal-title":"N. Engl. J. Med"},{"key":"53848_CR6","doi-asserted-by":"crossref","unstructured":"Molina-Franky, J. et al. The black box of cellular and molecular events of plasmodium vivax merozoite invasion into reticulocytes. Int. J. Mol. Sci. 23, 14528 (2022).","DOI":"10.3390\/ijms232314528"},{"key":"53848_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-135","volume":"11","author":"NM Douglas","year":"2012","unstructured":"Douglas, N. M. et al. The anaemia of Plasmodium vivax malaria. Malar. J. 11, 135 (2012).","journal-title":"Malar. J."},{"key":"53848_CR8","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.chom.2022.03.034","volume":"30","author":"L Mancio-Silva","year":"2022","unstructured":"Mancio-Silva, L. et al. A single-cell liver atlas of Plasmodium vivax infection. Cell Host Microbe 30, 1048\u20131060.e5 (2022).","journal-title":"Cell Host Microbe"},{"key":"53848_CR9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.4269\/ajtmh.20-0186","volume":"103","author":"RJ Commons","year":"2020","unstructured":"Commons, R. J. et al. Estimating the proportion of plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis. Am. J. Trop. Med Hyg. 103, 1094\u20131099 (2020).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"53848_CR10","doi-asserted-by":"publisher","first-page":"e1003561","DOI":"10.1371\/journal.pmed.1003561","volume":"18","author":"CS Chu","year":"2021","unstructured":"Chu, C. S. & White, N. J. The prevention and treatment of Plasmodium vivax malaria. PLoS Med 18, e1003561 (2021).","journal-title":"PLoS Med"},{"key":"53848_CR11","doi-asserted-by":"crossref","unstructured":"da Veiga, G. T. S., Moriggi, M. R., Vettorazzi, J. F., M\u00fcller-Santos, M. & Albrecht, L. Plasmodium vivax vaccine: What is the best way to go? Front. Immunol. 13, 910236 (2023).","DOI":"10.3389\/fimmu.2022.910236"},{"key":"53848_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.chom.2021.03.011","volume":"29","author":"C Schafer","year":"2021","unstructured":"Schafer, C. et al. Partial protection against P. vivax infection diminishes hypnozoite burden and blood-stage relapses. Cell Host Microbe 29, 752\u2013756.e4 (2021).","journal-title":"Cell Host Microbe"},{"key":"53848_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijpara.2016.09.006","volume":"47","author":"WH Tham","year":"2017","unstructured":"Tham, W. H., Beeson, J. G. & Rayner, J. C. Plasmodium vivax vaccine research \u2013 we\u2019ve only just begun. Int. J. Parasitol. 47, 111\u2013118 (2017).","journal-title":"Int. J. Parasitol."},{"key":"53848_CR14","doi-asserted-by":"crossref","unstructured":"Lamarque, M. et al. The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. Plos Pathogens, 7, e1001276 (2011).","DOI":"10.1371\/journal.ppat.1001276"},{"key":"53848_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/IAI.72.1.154-158.2004","volume":"72","author":"GH Mitchell","year":"2004","unstructured":"Mitchell, G. H. et al. Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect. Immun. 72, 154\u2013158 (2004).","journal-title":"Infect. Immun."},{"key":"53848_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.chom.2017.07.003","volume":"22","author":"AF Cowman","year":"2017","unstructured":"Cowman, A. F. et al. The molecular basis of erythrocyte invasion by malaria parasites. Cell Host Microbe 22, 232\u2013245 (2017).","journal-title":"Cell Host Microbe"},{"key":"53848_CR17","doi-asserted-by":"publisher","first-page":"e1010643","DOI":"10.1371\/journal.ppat.1010643","volume":"18","author":"P Fernandes","year":"2022","unstructured":"Fernandes, P. et al. The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts. PLoS Pathog. 18, e1010643 (2022).","journal-title":"PLoS Pathog."},{"key":"53848_CR18","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1074\/jbc.M311331200","volume":"279","author":"O Silvie","year":"2004","unstructured":"Silvie, O. et al. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 279, 9490\u20139496 (2004).","journal-title":"J. Biol. Chem."},{"key":"53848_CR19","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","volume":"387","author":"K Kayentao","year":"2022","unstructured":"Kayentao, K. et al. Safety and efficacy of a monoclonal antibody against malaria in mali. N. Engl. J. Med 387, 1833\u20131842 (2022).","journal-title":"N. Engl. J. Med"},{"key":"53848_CR20","volume":"4","author":"P Srinivasan","year":"2261","unstructured":"Srinivasan, P. et al. Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasion. Nat. Commun. 4, 2013 (2261).","journal-title":"Nat. Commun."},{"key":"53848_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.pt.2011.04.002","volume":"27","author":"JS Tyler","year":"2011","unstructured":"Tyler, J. S., Treeck, M. & Boothroyd, J. C. Focus on the ringleader: the role of AMA1 in apicomplexan invasion and replication. Trends Parasitol. 27, 410\u2013420 (2011).","journal-title":"Trends Parasitol."},{"key":"53848_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jsb.2015.02.008","volume":"190","author":"LE Boucher","year":"2015","unstructured":"Boucher, L. E. & Bosch, J. The apicomplexan glideosome and adhesins - structures and function. J. Struct. Biol. 190, 93\u2013114 (2015).","journal-title":"J. Struct. Biol."},{"key":"53848_CR23","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1073\/pnas.1110303108","volume":"108","author":"P Srinivasan","year":"2011","unstructured":"Srinivasan, P. et al. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc. Natl Acad. Sci. USA 108, 13275\u201313280 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"53848_CR24","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.1074\/jbc.M610562200","volume":"282","author":"CR Collins","year":"2007","unstructured":"Collins, C. R. et al. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J. Biol. Chem. 282, 7431\u20137441 (2007).","journal-title":"J. Biol. Chem."},{"key":"53848_CR25","first-page":"297","volume":"49","author":"JA Deans","year":"1982","unstructured":"Deans, J. A. et al. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin. Exp. Immunol. 49, 297\u2013309 (1982).","journal-title":"Clin. Exp. Immunol."},{"key":"53848_CR26","doi-asserted-by":"publisher","first-page":"e0183198","DOI":"10.1371\/journal.pone.0183198","volume":"12","author":"B Vulliez-Le Normand","year":"2017","unstructured":"Vulliez-Le Normand, B. et al. Cross-reactivity between apical membrane antgen 1 and rhoptry neck protein 2 in P. vivax and P. falciparum: a structural and binding study. PLoS One 12, e0183198 (2017).","journal-title":"PLoS One"},{"key":"53848_CR27","doi-asserted-by":"publisher","first-page":"e202200533","DOI":"10.1002\/cbic.202200533","volume":"24","author":"J Mannuthodikayil","year":"2023","unstructured":"Mannuthodikayil, J. et al. A Chimeric peptide inhibits red blood cell invasion by plasmodium falciparum with hundredfold increased efficacy. Chembiochem 24, e202200533 (2023).","journal-title":"Chembiochem"},{"key":"53848_CR28","doi-asserted-by":"publisher","first-page":"e2215003120","DOI":"10.1073\/pnas.2215003120","volume":"120","author":"SK Lee","year":"2023","unstructured":"Lee, S. K. et al. The direct binding of Plasmodium vivax AMA1 to erythrocytes defines a RON2-independent invasion pathway. Proc. Natl Acad. Sci. USA 120, e2215003120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"53848_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00018-023-04712-z","volume":"80","author":"DR Drew","year":"2023","unstructured":"Drew, D. R. et al. Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines. Cell Mol. Life Sci. 80, 74 (2023).","journal-title":"Cell Mol. Life Sci."},{"key":"53848_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/femsre\/fuw001","volume":"40","author":"JG Beeson","year":"2016","unstructured":"Beeson, J. G. et al. Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria. FEMS Microbiol Rev. 40, 343\u2013372 (2016).","journal-title":"FEMS Microbiol Rev."},{"key":"53848_CR31","doi-asserted-by":"crossref","unstructured":"L\u00f3pez, C., Yepes-P\u00e9rez, Y., Hincapi\u00e9-Escobar, N., D\u00edaz-Ar\u00e9valo, D. & Patarroyo, M.A. What is known about the immune response induced by plasmodium vivax malaria vaccine candidates? Front. Immunol. 8, 126 (2017).","DOI":"10.3389\/fimmu.2017.00126"},{"key":"53848_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/imr.12816","volume":"293","author":"LR Antonelli","year":"2020","unstructured":"Antonelli, L. R. et al. The immunology of Plasmodium vivax malaria. Immunol. Rev. 293, 163\u2013189 (2020).","journal-title":"Immunol. Rev."},{"key":"53848_CR33","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","volume":"69","author":"AN Hodder","year":"2001","unstructured":"Hodder, A. N., Crewther, P. E. & Anders, R. F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69, 3286\u20133294 (2001).","journal-title":"Infect. Immun."},{"key":"53848_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4269\/ajtmh.2001.65.100","volume":"65","author":"V Udhayakumar","year":"2001","unstructured":"Udhayakumar, V. et al. Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. Am. J. Trop. Med Hyg. 65, 100\u2013107 (2001).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"53848_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60551-z","volume":"10","author":"JA Bailey","year":"2020","unstructured":"Bailey, J. A. et al. Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination. Sci. Rep. 10, 3952 (2020).","journal-title":"Sci. Rep."},{"key":"53848_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpara.2004.11.003","volume":"35","author":"MH Rodrigues","year":"2005","unstructured":"Rodrigues, M. H. et al. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int J. Parasitol. 35, 185\u2013192 (2005).","journal-title":"Int J. Parasitol."},{"key":"53848_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.vaccine.2004.05.031","volume":"23","author":"SD Polley","year":"2004","unstructured":"Polley, S. D. et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23, 718\u2013728 (2004).","journal-title":"Vaccine"},{"key":"53848_CR38","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1016\/j.jmb.2019.05.018","volume":"431","author":"ND Salinas","year":"2019","unstructured":"Salinas, N. D., Tang, W. K. & Tolia, N. H. Blood-stage malaria parasite antigens: structure, function, and vaccine potential. J. Mol. Biol. 431, 4259\u20134280 (2019).","journal-title":"J. Mol. Biol."},{"key":"53848_CR39","doi-asserted-by":"publisher","unstructured":"Sinha, S., Biswas, A., Mondal, J. & Mandal, K. Computational and experimental studies of the breathing motion of a protein loop: implications in PfAMA1-PfRON2 late-stage binding event. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.10.10.463826 (2022).","DOI":"10.1101\/2021.10.10.463826"},{"key":"53848_CR40","doi-asserted-by":"publisher","first-page":"e0005791","DOI":"10.1371\/journal.pntd.0005791","volume":"11","author":"KE Swearingen","year":"2017","unstructured":"Swearingen, K. E. et al. Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites. PLoS Negl. Trop. Dis. 11, e0005791 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"53848_CR41","doi-asserted-by":"crossref","unstructured":"Arnott A. et al. Global population structure of the genes encoding the malaria vaccine candidate, plasmodium vivax apical membrane antigen 1 (PvAMA1). PLoS Negl. Trop. Dis. 7, e2506 (2013).","DOI":"10.1371\/journal.pntd.0002506"},{"key":"53848_CR42","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.1107449","volume":"308","author":"JC Pizarro","year":"2005","unstructured":"Pizarro, J. C. et al. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science 308, 408\u2013411 (2005).","journal-title":"Science"},{"key":"53848_CR43","doi-asserted-by":"publisher","first-page":"e0123567","DOI":"10.1371\/journal.pone.0123567","volume":"10","author":"B Vulliez-Le Normand","year":"2015","unstructured":"Vulliez-Le Normand, B. et al. Crystal structure of Plasmodium knowlesi apical membrane antigen 1 and its complex with an invasion-inhibitory monoclonal antibody. PLoS One 10, e0123567 (2015).","journal-title":"PLoS One"},{"key":"53848_CR44","doi-asserted-by":"publisher","first-page":"e1002755","DOI":"10.1371\/journal.ppat.1002755","volume":"8","author":"B Vulliez-Le Normand","year":"2012","unstructured":"Vulliez-Le Normand, B. et al. Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog. 8, e1002755 (2012).","journal-title":"PLoS Pathog."},{"key":"53848_CR45","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/IAI.74.5.2628-2636.2006","volume":"74","author":"AM Coley","year":"2006","unstructured":"Coley, A. M. et al. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect. Immun. 74, 2628\u20132636 (2006).","journal-title":"Infect. Immun."},{"key":"53848_CR46","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ymthe.2022.04.001","volume":"30","author":"M Aleshnick","year":"2022","unstructured":"Aleshnick, M. et al. Monoclonal antibodies for malaria prevention. Mol. Ther. 30, 1810\u20131821 (2022).","journal-title":"Mol. Ther."},{"key":"53848_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa2034031","volume":"385","author":"MR Gaudinski","year":"2021","unstructured":"Gaudinski, M. R. et al. A monoclonal antibody for malaria prevention. N. Engl. J. Med 385, 803\u2013814 (2021).","journal-title":"N. Engl. J. Med"},{"key":"53848_CR48","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S1473-3099(22)00793-9","volume":"23","author":"KE Lyke","year":"2023","unstructured":"Lyke, K. E. et al. Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial. Lancet Infect. Dis. 23, 578\u2013588 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"53848_CR49","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJMoa2312775","volume":"390","author":"K Kayentao","year":"2024","unstructured":"Kayentao, K. et al. Subcutaneous administration of a monoclonal antibody to prevent malaria. N. Engl. J. Med 390, 1549\u20131559 (2024).","journal-title":"N. Engl. J. Med"},{"key":"53848_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep39462","volume":"6","author":"DJ Maskus","year":"2016","unstructured":"Maskus, D. J. et al. Characterization of a novel inhibitory human monoclonal antibody directed against plasmodium falciparum apical membrane antigen 1. Sci. Rep. 6, 39462 (2016).","journal-title":"Sci. Rep."},{"key":"53848_CR51","doi-asserted-by":"publisher","first-page":"15644","DOI":"10.1074\/jbc.M109.092619","volume":"285","author":"J Crawford","year":"2010","unstructured":"Crawford, J. et al. Structural characterization of apical membrane antigen 1 (AMA1) from Toxoplasma gondii. J. Biol. Chem. 285, 15644\u201315652 (2010).","journal-title":"J. Biol. Chem."},{"key":"53848_CR52","first-page":"498","volume":"217","author":"R Damien","year":"2017","unstructured":"Damien, R. et al. Beeson, functional conservation of the ama1 host-cell invasion ligand between p. falciparum and p. vivax: a novel platform to accelerate vaccine and drug development. J. Infect. Dis. 217, 498\u2013507 (2017).","journal-title":"J. Infect. Dis."},{"key":"53848_CR53","doi-asserted-by":"crossref","unstructured":"Kucharska, I. et al. Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats. Elife 11, e72908 (2022).","DOI":"10.7554\/eLife.72908"},{"key":"53848_CR54","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","volume":"17","author":"SA Mikolajczak","year":"2015","unstructured":"Mikolajczak, S. A. et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 17, 526\u2013535 (2015).","journal-title":"Cell Host Microbe"},{"key":"53848_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cmdc.201800802","volume":"14","author":"M Akter","year":"2019","unstructured":"Akter, M. et al. Identification of the binding site of apical membrane antigen 1 (ama1) inhibitors using a paramagnetic probe. ChemMedChem 14, 603\u2013612 (2019).","journal-title":"ChemMedChem"},{"key":"53848_CR56","doi-asserted-by":"publisher","first-page":"e0144764","DOI":"10.1371\/journal.pone.0144764","volume":"11","author":"RF Delgadillo","year":"2016","unstructured":"Delgadillo, R. F. et al. Stability of the plasmodium falciparum AMA1-RON2 Complex Is Governed by the Domain II (DII) Loop. PLoS One 11, e0144764 (2016).","journal-title":"PLoS One"},{"key":"53848_CR57","doi-asserted-by":"publisher","first-page":"e0126206","DOI":"10.1371\/journal.pone.0126206","volume":"10","author":"ML Parker","year":"2015","unstructured":"Parker, M. L. & Boulanger, M. J. An extended surface loop on toxoplasma gondii apical membrane antigen 1 (ama1) governs ligand binding selectivity. PLoS One 10, e0126206 (2015).","journal-title":"PLoS One"},{"key":"53848_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1126\/science.1204988","volume":"333","author":"ML Tonkin","year":"2011","unstructured":"Tonkin, M. L. et al. Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 333, 463\u2013467 (2011).","journal-title":"Science"},{"key":"53848_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A., Recht, J. & White, N. J. Primaquine: the risks and the benefits. Malar. J. 13, 418 (2014).","journal-title":"Malar. J."},{"key":"53848_CR60","doi-asserted-by":"publisher","first-page":"e0126747","DOI":"10.1371\/journal.pone.0126747","volume":"10","author":"C Koepfli","year":"2015","unstructured":"Koepfli, C. et al. Blood-Stage parasitaemia and age determine plasmodium falciparum and p. vivax gametocytaemia in papua new guinea. PLoS One 10, e0126747 (2015).","journal-title":"PLoS One"},{"key":"53848_CR61","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/protein\/14.9.691","volume":"14","author":"AM Coley","year":"2001","unstructured":"Coley, A. M. et al. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. Protein Eng. 14, 691\u2013698 (2001).","journal-title":"Protein Eng."},{"key":"53848_CR62","first-page":"1308","volume":"3","author":"AM Coley","year":"2007","unstructured":"Coley, A. M. et al. Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog. 3, 1308\u20131319 (2007).","journal-title":"PLoS Pathog."},{"key":"53848_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40878-7","volume":"14","author":"PN Patel","year":"2023","unstructured":"Patel, P. N. et al. Structure-based design of a strain transcending AMA1-RON2L malaria vaccine. Nat. Commun. 14, 5345 (2023).","journal-title":"Nat. Commun."},{"key":"53848_CR64","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.pt.2022.05.014","volume":"38","author":"AL Valenciano","year":"2022","unstructured":"Valenciano, A. L. et al. In vitro models for human malaria: targeting the liver stage. Trends Parasitol. 38, 758\u2013774 (2022).","journal-title":"Trends Parasitol."},{"key":"53848_CR65","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.immuni.2024.05.001","volume":"57","author":"IN Nkumama","year":"2024","unstructured":"Nkumama, I. N. et al. Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge. Immunity 57, 1215\u20131224.e6 (2024).","journal-title":"Immunity"},{"key":"53848_CR66","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.4049\/jimmunol.1801631","volume":"202","author":"LL Carias","year":"2019","unstructured":"Carias, L. L. et al. Identification and characterization of functional human monoclonal antibodies to plasmodium vivax duffy-binding protein. J. Immunol. 202, 2648\u20132660 (2019).","journal-title":"J. Immunol."},{"key":"53848_CR67","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/molbev\/msu340","volume":"32","author":"A Mirsky","year":"2015","unstructured":"Mirsky, A., Kazandjian, L. & Anisimova, M. Antibody-specific model of amino acid substitution for immunological inferences from alignments of antibody sequences. Mol. Biol. Evol. 32, 806\u2013819 (2015).","journal-title":"Mol. Biol. Evol."},{"key":"53848_CR68","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1128\/JCM.44.5.1665-1673.2006","volume":"44","author":"KE Persson","year":"2006","unstructured":"Persson, K. E. et al. Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies. J. Clin. Microbiol 44, 1665\u20131673 (2006).","journal-title":"J. Clin. Microbiol"},{"key":"53848_CR69","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","volume":"10","author":"C Ritz","year":"2015","unstructured":"Ritz, C. et al. Dose-response analysis using R. PLoS One 10, e0146021 (2015).","journal-title":"PLoS One"},{"key":"53848_CR70","doi-asserted-by":"crossref","unstructured":"Wickham, H. and SpringerLink, Ggplot2: elegant graphics for data analysis. 1st 2009. ed. Use R! 2009, Dordrecht; New York New York, NY: Springer Springer New York.","DOI":"10.1007\/978-0-387-98141-3_1"},{"key":"53848_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14574-9","volume":"11","author":"J Popovici","year":"2020","unstructured":"Popovici, J. et al. Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunity. Nat. Commun. 11, 953 (2020).","journal-title":"Nat. Commun."},{"key":"53848_CR72","doi-asserted-by":"crossref","unstructured":"Rangel, G. W. et al. Enhanced ex vivo plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays. Antimicrob. Agents Chemother. 62, e02519-17 (2018).","DOI":"10.1128\/AAC.02519-17"},{"key":"53848_CR73","doi-asserted-by":"crossref","unstructured":"Sack, B. K. et al. Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice. NPJ Vaccines, 2, 27 (2017).","DOI":"10.1038\/s41541-017-0028-2"},{"key":"53848_CR74","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.4269\/ajtmh.19-0094","volume":"100","author":"AM Seilie","year":"2019","unstructured":"Seilie, A. M. et al. Beyond blood smears: qualification of plasmodium 18s rrna as a biomarker for controlled human malaria infections. Am. J. Trop. Med Hyg. 100, 1466\u20131476 (2019).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"53848_CR75","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","volume":"11","author":"AM Vaughan","year":"2009","unstructured":"Vaughan, A. M. et al. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol 11, 506\u2013520 (2009).","journal-title":"Cell Microbiol"},{"key":"53848_CR76","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4269\/ajtmh.2009.80.218","volume":"80","author":"FB Ntumngia","year":"2009","unstructured":"Ntumngia, F. B. et al. Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am. J. Trop. Med Hyg. 80, 218\u2013227 (2009).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"53848_CR77","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1107\/S1600577518003120","volume":"25","author":"DA Aragao","year":"2018","unstructured":"Aragao, D. A. et al. MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron. J. Synchrotron Radiat. 25, 885\u2013891 (2018).","journal-title":"J. Synchrotron Radiat."},{"key":"53848_CR78","first-page":"125","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Struct. Biol. 66, 125\u2013132 (2010).","journal-title":"Struct. Biol."},{"key":"53848_CR79","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41591-019-0568-2","volume":"25","author":"A Cassotta","year":"2019","unstructured":"Cassotta, A. et al. A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients. Nat. Med 25, 1402\u20131407 (2019).","journal-title":"Nat. Med"},{"key":"53848_CR80","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P. et al. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"53848_CR81","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D. Biol. Crystallogr 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53848-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53848-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T06:07:11Z","timestamp":1733292431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53848-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53848"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53848-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3888852\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10556"}}